Exploring Genetic Effects in Cells 11 March 2010 A deep look into population variation in gene activity provides key insight to cell functions and disease susceptibility, researcher report.
Study Identifies Single microRNA Biomarker for Prognosis of Mesothelioma Patients 18 February 2010 Demonstrate potential of miR-29c* to act as an independent prognostic factor for time to progression as well as survival after surgery.
Automating Viral RNA Genotyping 18 February 2010 Agilent Automation Solutions has released a new applications bulletin that describes an automated system for rapid characterization of pathogens, including for example the Influenza A (H1N1) virus.
PBL InterferonSource: 20 Years of Interferon Excellence 18 February 2010 Celebrating the 20th anniversary of its expertise in the field of interferons
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients 17 February 2010 Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
MDRNA, Inc. Reports Positive Results for its Proprietary siRNA Delivery Technology 09 February 2010 Data demonstrates the potential for long-term stability of drug products.
Mirrx Therapeutics Secures Seed Financing for Development of microRNA- blocking Technology 09 February 2010 Finances will enable the company to achieve in vivo proof of concept for its microRNA-blocking Blockmir technology.
OGI Announces Genomics Technology Seeding Award to UHN Microarray Centre 08 February 2010 UHN Microarray Centre will receive $10,000 to evaluate several RNA amplification methods to extend the applicability of the nCounter™ system.